Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9 EUR | -1.64% | +1.69% | -1.64% |
27/05 | Toray Industries to Build Advanced Materials Production Plant in South Korea's Gumi City | MT |
22/05 | Immunis Partners with Toray to Reverse Sarcopenia | CI |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- The company is highly valued given the cash flows generated by its activity.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.64% | 8.15B | - | ||
+1.73% | 103B | A- | ||
-9.58% | 60.12B | A- | ||
+74.29% | 48.78B | B | ||
+17.72% | 39.05B | B | ||
+2.37% | 32.14B | A- | ||
+12.18% | 20.44B | B- | ||
+12.59% | 16.97B | C+ | ||
+11.16% | 14.26B | B- | ||
+0.19% | 13.66B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3402 Stock
- 6HK Stock
- Ratings Toray Industries, Inc.